A total of 220 patients (106 receiving metoprolol, 114 controls) were included in the analysis. Relative to controls, infarct size was significantly lower (25.6 ± 15.3 vs 32.0 ± 22.2 g; p = .012 ...

Topline results were announced from a phase 3 study comparing aficamten with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). The randomized, double-blind ...